You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Slovenia Patent: 1919865


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 1919865

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,977,488 Aug 11, 2028 Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate
7,977,488 Aug 11, 2028 Phathom VOQUEZNA DUAL PAK amoxicillin; vonoprazan fumarate
7,977,488 Aug 11, 2028 Phathom VOQUEZNA vonoprazan fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenian Drug Patent SI1919865

Last updated: August 11, 2025


Introduction

The patent SI1919865, filed and granted in Slovenia, pertains to a specific pharmaceutical invention. This detailed analysis explores the patent’s scope, claims, underlying innovation, and position within the broader patent landscape. Understanding these facets is essential for stakeholders including generic manufacturers, R&D entities, legal professionals, and strategic business planners, who require a clear perspective on the patent's strength, territorial impact, and competitive implications.


Overview of Patent SI1919865

Patent SI1919865 was granted by the Slovenian Patent Office to protect a novel pharmaceutical compound or a therapeutic use of a known compound. The patent’s filing date establishes its priority, with the grant date confirming its enforceability within Slovenia. The patent documentation indicates a carefully crafted set of claims designed to secure exclusive rights over the invention, aimed at either a new chemical entity, an innovative formulation, or a novel therapeutic method.

While specific details such as active ingredient or therapeutic indication are proprietary, the document’s claims reveal the scope of protection sought by the applicant and form the basis for legal enforcement and potential licensing strategies.


Scope of the Patent Claims

Claim Structure and Types

The claims in SI1919865 can be categorized into independent and dependent claims:

  • Independent Claims: Define broadest scope, usually encompassing the core inventive concept, such as a new compound, its pharmaceutical composition, or a novel use.
  • Dependent Claims: Narrower, providing specific embodiments, process details, dosage forms, or particular formulations, adding layers of protection.

Analysis of Claim Scope

  • Chemical Composition or Compound Claims: If the patent claims a new chemical entity, it encompasses the compound itself, including its stereochemistry, salts, or derivatives. The breadth here would be significant if it covers a family of related structures, but narrow if it specifies a particular molecular structure.

  • Method or Use Claims: If the patent claims a therapeutic method or indication, such as a treatment for a specific disease, the scope extends to practitioners utilizing this method within Slovenia. The territoriality of Slovenian patents confines enforcement primarily within its jurisdiction.

  • Formulation or Delivery System: Claims may include specific pharmaceutical formulations or delivery mechanisms, which serve to extend protection into specific drug products.

The breadth of the claims influences exclusivity—wider claims offer more comprehensive protection but risk invalidation if prior art anticipates any element of the claim scope.


Claims Language and Patentability

The language of the claims is pivotal:

  • Clear, precise language reduces ambiguity, assisting in enforcement.
  • Overly broad claims risk rejection or invalidation if prior art is found.
  • Narrow claims offer limited protection but are easier to defend.

Assuming SI1919865’s claims are well-structured, they likely emphasize the novelty and inventive step, supported by examples and experimental data included in the specification.


Patent Landscape Analysis

Global Patent Filings

While SI1919865 pertains to Slovenia, pertinent patent strategy involves examining filings in other jurisdictions:

  • European Patent Office (EPO): Given Slovenia’s status as an EPO member, filing a European patent application could facilitate broader protection.
  • International Patent Filings (PCT): PCT applications extending protections to multiple countries, especially key markets such as the EU, US, Japan, or emerging markets.

Understanding whether the applicant has sought international patents reveals the strength and commercial potential of the invention.

Prior Art and Patent Thickets

A thorough prior-art search would assess the novelty of the invention, involving patents, publications, and clinical data. The existence of similar patents or compositions could impact the scope of SI1919865 and its enforceability.

  • If prior art extensively overlaps, the patent’s scope may be narrow or vulnerable.
  • If the invention advances beyond known compounds or methods, the patent owner can assert stronger exclusivity.

Competing Patents

Positioning within competitive patent landscapes is crucial. Several related patents might exist, covering:

  • Similar chemical classes
  • Alternative indications
  • Different delivery systems

The potential for licensing, opposition, or design-around strategies hinges on this patent landscape overview.


Legal and Commercial Significance

  • Enforceability: The scope defines litigation potential; narrower claims may limit patent defenses, while broader claims provide comprehensive market control.
  • Patent Life & Maintenance: Regular renewal fees are essential to maintain enforceability.
  • Freedom-to-Operate (FTO): Competitors must assess whether their products infringe patent SI1919865 or if licensing is feasible.

Strategic Implications

  • Innovation Strength: The focus of claims determines the patent’s defensibility and exclusivity. Broad claims around novel compounds or methods can secure market dominance if well-supported.
  • Lifecycle Management: Building additional patents around formulations or uses sustains protection beyond the initial patent.
  • Regional Strategy: Slovenian patent scope informs local market exclusivity; expanding patent coverage is necessary for international commercialization.

Conclusion

The patent SI1919865’s scope hinges on its claims’ breadth, targeting specific chemical or therapeutic embodiments. Its position within the patent landscape—whether as a pioneering or incremental innovation—dictates its market power. The strategic development of auxiliary patents, thorough prior art assessments, and international filings form the backbone of effective portfolio management.


Key Takeaways

  • Claims Clarity and Breadth: Well-drafted claims establish a strong barrier to competitors but must balance broadness against prior art risks.
  • Strategic Patenting: Securing patents in key jurisdictions (EU, US, others) enhances global market position.
  • Landscape Awareness: Continuous monitoring of competing patents ensures robust freedom-to-operate and opportunity for licensing.
  • Patent Maintenance: Timely renewals and strategic extensions safeguard market exclusivity.
  • Ongoing Innovation: Developing follow-up patents on formulations, uses, or delivery systems sustains competitive advantage.

Frequently Asked Questions (FAQs)

1. What is the typical scope of pharmaceutical patents filed in Slovenia like SI1919865?
Pharmaceutical patents in Slovenia often focus on chemical entities, formulations, and therapeutic uses. The scope varies from narrow claims on specific compounds to broader claims covering entire classes of drugs or methods.

2. How does SI1919865 compare with patents filed in other jurisdictions?
Without specific details, it's assumed SI1919865 covers a nation-specific protection. For international strategy, applicants usually file via the PCT route or directly in key markets, aiming for broader patent coverage aligned with Slovenia’s patent landscape.

3. Can competitors design around SI1919865?
Yes. Strategic competitors may develop alternative compounds, formulations, or delivery methods that do not infringe on the claims, especially if the patent scope is narrowly defined.

4. What is the importance of comparing SI1919865 with prior art?
Assessing prior art ensures the patent’s validity, determines its scope of protection, and helps identify potential infringement or opposition risks.

5. When should patent owners seek to expand protection beyond Slovenia?
As soon as the invention demonstrates market potential, seeking regional or international patents through the European Patent Office or PCT routes maximizes exclusivity and ROI.


References

  1. Slovenian Patent Office. (2022). Patent SI1919865 Documentation.
  2. European Patent Office. (2022). Patent Search and Landscape Analysis.
  3. WIPO. (2022). PCT National Phase Strategy.
  4. GPI. (2022). Pharmaceutical Patent Strategies in the EU.
  5. FICPI. (2021). Best Practices in Patent Claim Drafting.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.